Saladax Biomedical Inc., a Bethlehem-based firm whose merchandise assist sufferers obtain right dosages of medication, has reached a worldwide distribution settlement with Beckman Coulter Inc.
Beckman Coulter will distribute MyCare Psychiatry Laboratory Assays, which measure drug ranges of antipsychotic medicine used to deal with critical psychological diseases reminiscent of schizophrenia and bipolar dysfunction, in accordance with a Saladax assertion distributed Tuesday.
Saladax’s assays run on automated scientific analyzers, dashing up the time to outcomes.
“Along with Beckman Coulter Inc., a number one world producer of automated scientific analyzers, we’ll enormously enhance entry to this testing to enhance the care of sufferers with critical psychological sickness,” stated Sal Salamone, founder and chief government officer of Saladax. The corporate is privately held and primarily based at 116 Analysis Drive in Bethlehem.
Critical psychological sickness is a public well being concern with an financial affect in america of greater than $300 billion yearly, in accordance with Saladax. Greater than 13 million adults within the U.S. skilled critical psychological sickness prior to now yr, or about 5% of the grownup inhabitants. Schizophrenia and bipolar dysfunction account for greater than $88 billion in direct healthcare prices, the Saladax assertion stated.
Saladax says on its web site that since 2007, its expertise has been used to assist monitor affected person care. The corporate additionally works with pharmaceutical firms to develop assessments for scientific trials.
“We imagine that really personalised medication can solely exist when the correct drug is taken on the proper dose,” in accordance with the Saladax web site.
Beckman Coulter, a subsidiary of Danaher Corp., additionally put out an announcement on the settlement. Neither firm disclosed monetary phrases.
“Our relationship with Saladax expands entry for laboratories and clinicians to antipsychotic drug testing for therapy of psychotic issues, which is a rising healthcare want,” stated Kathleen Orland, senior vp and basic supervisor of scientific chemistry and immunoassay for Beckman Coulter.